Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan and Hydrochlorothiazide Combined and Alone, in Patients With Metabolic Syndrome

NCT00170937 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00170937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan and Hydrochlorothiazide Combined and Alone, in Patients With Metabolic Syndrome
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
Not reported
Enrollment
507
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, metabolic syndrome, pre-hypertension